Study finds low risk for jaw osteonecrosis with denosumab for postmenopausal osteoporosisSeptember 9, 2017OsteoporosisMenopause
Romosozumab cuts new vertebral fracture risk by 73%, but safety data are concerningJune 15, 2017OsteoporosisMenopause
Updated osteoporosis guideline advocates bisphosphonates, nixes estrogensMay 8, 2017MenopauseOsteoporosis
Study shows no adverse events with long-term denosumab in postmenopausal womenApril 14, 2017OsteoporosisMenopause
New guidance: Bone health is front and center in functional hypothalamic amenorrhea careMarch 25, 2017Reproductive EndocrinologyOsteoporosis
Large, intermittent vitamin D doses may increase fracture, fall risk in elderlyMarch 3, 2017Rare DiseasesOsteoporosis
